A 32-year-old mother comes to your pediatric clinic with her 4-year-old son who has Down syndrome (trisomy 21). The child was diagnosed postnatally with a karyotype confirming standard trisomy 21 (47,XY,+21). The mother is now planning to conceive another child. She is very anxious and asks:
"Doctor, my son has Down syndrome. I love him very much, but it has been very challenging. Now I want to have another baby. What is the chance that my next baby will also have Down syndrome? Can we test for it during pregnancy? Is there anything we can do to prevent it? Should we see a genetic specialist? I am so scared."
The mother is otherwise healthy. She has no other children. There is no family history of Down syndrome or other genetic disorders. She is not taking any medications and is on folic acid 400 mcg daily (started recently). Her husband is 35 years old and healthy.
Task for the candidate: You are the pediatrician. Counsel the mother about the recurrence risk of Down syndrome, the importance of genetic counseling, prenatal screening options (first trimester combined test, NIPT, quadruple screen), diagnostic tests (CVS, amniocentesis), and the role of folic acid. Address her anxiety and provide a clear, empathetic, evidence-based plan. The examiner will observe your interaction and communication skills.
π‘ Examiner instruction (interactive β observed counseling):
β’ The candidate must demonstrate empathy, active listening, and clear communication.
β’ Use simple, non-technical language initially, then introduce terms appropriately.
β’ Address the mother's anxiety first ("Your feelings are completely understandable", "We will go through this step by step").
β’ Explain: recurrence risk depends on the type of Down syndrome (standard trisomy 21 ~1% plus age-related risk; translocation ~10-15% if mother is carrier).
β’ Discuss the need for parental karyotyping (to rule out translocation carrier status) BEFORE next pregnancy.
β’ Discuss prenatal screening and diagnostic options: NIPT (high sensitivity), combined first trimester screening, quad screen, CVS (11-14 weeks), amniocentesis (15-20 weeks).
β’ Mention that folic acid does not prevent Down syndrome (it prevents neural tube defects).
β’ Offer genetic counseling referral.
β’ Provide psychosocial support and address her fears about raising another child with special needs.
β’ The examiner will then ask the candidate specific questions from the Q&A tab.
π¬ Model Counseling Script β Candidate's Interaction with Mother
π£οΈ Candidate's structured counseling (to be delivered to the mother):
1. Acknowledge and empathize:
βThank you for sharing your concerns. I understand that raising a child with Down syndrome, while rewarding, also comes with many challenges. It is completely normal to be worried about another pregnancy. You have come to the right place, and we will go through this together.β
2. Ask for more information (to guide recurrence risk):
βTo give you the most accurate information, I need to know: Was your sonβs Down syndrome the standard type (trisomy 21) or was it a translocation? Do you have the genetic report?β (Mother confirms standard trisomy 21).
3. Explain recurrence risk (standard trisomy 21):
βBecause your son has the most common type (trisomy 21), the chance of having another baby with Down syndrome is about 1% (1 in 100) PLUS the risk related to your age at delivery. At age 32, the baseline risk is about 1 in 600. So the combined risk is roughly 1 in 100 (1%) β which is higher than for a mother your age who hasn't had a child with Down syndrome. But it also means there is a 99% chance the baby will NOT have Down syndrome.β
4. Recommend parental karyotyping:
βBefore you try to conceive, I strongly recommend that both you and your husband have a blood test called a karyotype. This looks at your chromosomes. In a very small number of cases, a parent carries a βbalanced translocationβ that does not affect their health but increases the recurrence risk to 10-15% or more. If your karyotypes are normal (which they likely are), the risk is about 1% as I mentioned.β
5. Discuss prenatal screening and diagnostic tests (options):
βOnce you are pregnant, you have several options to test the baby for Down syndrome. None of these tests can prevent Down syndrome, but they can tell you if the baby has it, so you can prepare or make decisions.β
β’ Screening tests (non-invasive, estimate risk):
β First trimester combined test (ultrasound + blood) at 11-14 weeks.
β NIPT (cell-free fetal DNA) β very accurate (99% sensitivity) for trisomy 21, done after 10 weeks.
β Quadruple screen (second trimester, less accurate).
β’ Diagnostic tests (invasive, confirm diagnosis):
β Chorionic villus sampling (CVS) at 11-14 weeks β examines placental tissue. Small risk of miscarriage (~0.2-0.5%).
β Amniocentesis at 15-20 weeks β examines amniotic fluid. Small risk of miscarriage (~0.1-0.3%).
βMany women in your situation choose NIPT first because it is very accurate and safe. If NIPT is high-risk, they can then decide about diagnostic testing.β
6. Address folic acid:
βYou mentioned you are taking folic acid. That is excellent β it prevents neural tube defects like spina bifida. However, folic acid does NOT prevent Down syndrome. Keep taking it, but do not expect it to affect the risk of Down syndrome.β
7. Recommend genetic counseling:
βI strongly recommend you see a genetic counselor or a clinical geneticist. They can explain all of these tests in more detail, help you decide what is right for you, and arrange the parental karyotype test.β
8. Address her fears and provide psychosocial support:
βI know you are scared. Many parents in your situation go on to have healthy children. Even if the next child has Down syndrome, you already have experience and love to give. But you also have the right to know and to make choices. There is no wrong decision β only what is right for your family. We will support you either way.β
9. Summarize and close:
βTo summarize: First, you and your husband should get a karyotype blood test. Then, when you are pregnant, we will offer you NIPT or other screening tests, and if you wish, diagnostic testing (CVS or amniocentesis). Please see a genetic counselor. Your recurrence risk is about 1% if karyotypes are normal. Do not blame yourself β you did nothing wrong. I am here to help.β
π Examiner observation points (communication skills):
β’ Did the candidate introduce themselves and listen actively?
β’ Did they demonstrate empathy and validate the motherβs anxiety?
β’ Did they ask about the type of Down syndrome and obtain parental ages?
β’ Did they explain recurrence risk clearly (1% plus age risk)?
β’ Did they recommend parental karyotyping to rule out translocation?
β’ Did they discuss prenatal screening (NIPT, combined test) and diagnostic options (CVS, amniocentesis) with risks and benefits?
β’ Did they address folic acid correctly (does NOT prevent Down syndrome)?
β’ Did they recommend genetic counseling?
β’ Did they provide psychosocial support and avoid judgment?
β’ Did they summarize and provide a clear plan?
π Examiner Questions (after counseling) β Click to reveal model answers
β Q1 (Examiner): βWhat are the three cytogenetic types of Down syndrome? What are their approximate frequencies and recurrence risks?β
β Candidate's answer:
β’ Standard trisomy 21 (47,XX,+21 or 47,XY,+21): ~95% of cases. Due to nondisjunction during meiosis. Recurrence risk ~1% plus maternal age-related risk.
β’ Translocation Down syndrome: ~3-4% of cases. Most commonly Robertsonian translocation between chromosome 14 and 21 (or 21;21). Recurrence risk depends on carrier status:
- If mother is carrier (balanced translocation): ~10-15% risk.
- If father is carrier: ~2-3% risk.
- If de novo (parents normal): ~1-2% risk.
β’ Mosaicism: ~1-2% of cases. Some cells have trisomy 21, some are normal. Recurrence risk is low (<1%).
β’ Key takeaway: Parental karyotyping is essential to determine recurrence risk, especially for translocation.
β Q2 (Examiner): βWhat is the baseline risk of Down syndrome by maternal age at delivery? Provide approximate risks for age 30, 35, 40, and 45.β
β Candidate's answer:
β’ Age 20: 1 in 1,500
β’ Age 25: 1 in 1,350
β’ Age 30: 1 in 900
β’ Age 35: 1 in 350
β’ Age 40: 1 in 100
β’ Age 45: 1 in 30
β’ Age 49: 1 in 10
β’ The risk increases exponentially with maternal age due to increased nondisjunction during oogenesis.
β’ For this mother (age 32), baseline risk is ~1 in 600. After one affected child with standard trisomy 21, recurrence risk is ~1% (1 in 100) β which is higher than her age-related risk alone.
β Q3 (Examiner): βWhy do you recommend parental karyotyping for this mother? What would you do if the mother is found to be a balanced translocation carrier?β
β Candidate's answer:
β’ Purpose: To determine if either parent carries a balanced Robertsonian translocation involving chromosome 21. This is not detectable by physical examination and does not affect parental health, but it significantly increases recurrence risk (10-15% if mother is carrier).
β’ In standard trisomy 21 (95% of cases), parents are usually normal. But testing is recommended because if a translocation is found, the recurrence risk is much higher and prenatal diagnosis (CVS/amniocentesis) becomes even more critical.
β’ If mother is a translocation carrier:
- Recurrence risk ~10-15% for each pregnancy.
- Offer CVS or amniocentesis in all future pregnancies.
- Refer to genetic counselor to discuss options, including preimplantation genetic testing (PGT) with IVF.
- Other family members may also be at risk and should be offered testing.
β’ If both parents have normal karyotypes, recurrence risk is ~1% (maternal age-related + 1%).
β Q4 (Examiner): βWhat is NIPT (Non-Invasive Prenatal Testing)? How accurate is it for Down syndrome? What are its limitations?β
β Candidate's answer:
β’ NIPT: Cell-free fetal DNA (cffDNA) analysis from maternal blood (after 10 weeks). cffDNA comes from the placenta. Highly accurate for common aneuploidies (trisomy 21, 18, 13).
β’ Sensitivity for trisomy 21: >99% (99.7%). Specificity: >99.9%.
β’ Positive predictive value (PPV): Varies with maternal age and prevalence. In high-risk populations, PPV is very high (90-99%). In low-risk populations, false positives can occur.
β’ Limitations:
- Screening test, NOT diagnostic. Positive result must be confirmed by CVS or amniocentesis.
- Cannot detect all translocations or mosaicism.
- May fail due to low fetal fraction (obesity, early gestation).
- Does not assess risk for neural tube defects.
- Confined placental mosaicism can cause false positives or false negatives.
β’ NIPT is superior to traditional serum screening (quad screen) but is not diagnostic.
β Q5 (Examiner): βWhat does the first trimester combined screening test for Down syndrome include? What are its sensitivity and false positive rate?β
β Candidate's answer:
β’ Components (performed at 11-14 weeks):
1οΈβ£ Ultrasound (nuchal translucency β NT): Increased NT (>3.5 mm or >99th percentile) is associated with Down syndrome and other aneuploidies.
2οΈβ£ Maternal serum markers:
- PAPP-A (pregnancy-associated plasma protein-A): Low in Down syndrome.
- Free Ξ²-hCG: High in Down syndrome.
β’ Detection rate (sensitivity): ~85-90% for trisomy 21 at a false positive rate of 5%.
β’ Advantage: Also screens for trisomy 18 (low PAPP-A, low Ξ²-hCG, low NT) and can detect major structural anomalies.
β’ Disadvantage: Less sensitive than NIPT, higher false positive rate.
β’ If NIPT is available, it is preferred over first trimester combined screen in high-risk situations (prior affected child).
β Q6 (Examiner): βCompare chorionic villus sampling (CVS) and amniocentesis for prenatal diagnosis of Down syndrome. What are the risks and timing?β
β Candidate's answer:
β’ CVS:
- Timing: 11-14 weeks.
- Sample: Placental tissue (chorionic villi).
- Result: Karyotype/FISH in 1-2 days; final karyotype in 7-14 days.
- Risk of miscarriage: ~0.2-0.5% (slightly higher than amniocentesis).
- Limitation: Confined placental mosaicism (~1%) may not reflect fetal karyotype β may need follow-up amniocentesis.
- Advantage: Early diagnosis (first trimester).
β’ Amniocentesis:
- Timing: 15-20 weeks (can be done earlier 15-16 weeks).
- Sample: Amniotic fluid (fetal cells).
- Result: FISH 1-3 days; final karyotype 7-14 days.
- Risk of miscarriage: ~0.1-0.3%.
- Advantage: Lower miscarriage risk, more definitive (fetal cells).
- Disadvantage: Later diagnosis (second trimester).
β’ Both are diagnostic. Choice depends on gestational age, patient preference, and local expertise.
β Q7 (Examiner): βThe mother is taking folic acid. Does folic acid prevent Down syndrome? What is the recommended dose for her?β
β Candidate's answer:
β’ Folic acid does NOT prevent Down syndrome. Down syndrome is caused by a chromosomal abnormality, not a folate deficiency.
β’ Folic acid prevents neural tube defects (spina bifida, anencephaly).
β’ Recommended dose for this mother (no prior child with NTD):400-800 mcg (0.4-0.8 mg) daily, starting at least 1 month before conception and continuing through first trimester.
β’ If the mother had a prior child with a neural tube defect, the dose would be 4 mg daily (high dose).
β’ Continue folic acid, but do not expect it to reduce Down syndrome risk.
β Q8 (Examiner): βWhy do you recommend referral to a genetic counselor? What specific services can they provide?β
β Candidate's answer:
β’ Genetic counselors are specialists in risk calculation, test interpretation, and psychosocial support.
β’ Services they provide:
- Obtain detailed family history and draw a pedigree.
- Explain recurrence risk more precisely based on karyotype results.
- Arrange parental karyotyping and interpret results.
- Discuss all prenatal screening and diagnostic options (NIPT, CVS, amniocentesis) with risks/benefits.
- Discuss preimplantation genetic testing (PGT) if translocation is found.
- Provide emotional support and help with decision-making.
- Coordinate with maternal-fetal medicine specialists.
- Discuss testing for other family members if a translocation is found.
β’ A pediatrician can provide initial counseling but should refer to a genetic counselor for comprehensive care.
β Q9 (Examiner): βIf the mother is found to have a balanced Robertsonian translocation (e.g., 45,XX,der(14;21)(q10;q10)), what is the recurrence risk for Down syndrome in future pregnancies? Why is it different for male and female carriers?β
β Candidate's answer:
β’ If mother is carrier (female): Recurrence risk ~10-15% (some studies say up to 15%).
β’ If father is carrier (male): Recurrence risk ~2-3%.
β’ Reason for difference: In male spermatogenesis, balanced translocations more often segregate to result in normal or balanced sperm, whereas in female oogenesis, segregation abnormalities are more common due to the prolonged meiotic arrest and different selection pressures.
β’ In a Robertsonian translocation between 14 and 21, the carrier parent has 45 chromosomes (normal function). Possible gametes: normal, balanced carrier, trisomy 21, monosomy 21 (lethal). The liveborn risks are higher for female carriers.
β’ Parental karyotyping is essential to determine carrier status and recurrence risk.
β Q10 (Examiner): βWhat is preimplantation genetic testing (PGT) and how could it help this mother if she is a translocation carrier?β
β Candidate's answer:
β’ PGT (formerly PGD): Genetic testing of embryos created by in vitro fertilization (IVF) before implantation. Only embryos without the chromosomal abnormality are transferred.
β’ For a translocation carrier mother:
- PGT can identify embryos that are euploid (normal) or balanced translocation carriers (unaffected phenotype) versus those with trisomy 21 (unbalanced).
- This allows the mother to avoid conceiving a pregnancy with Down syndrome and avoid the need for prenatal diagnosis and potential termination.
- However, IVF is expensive, invasive, and not always successful.
β’ PGT is usually offered when recurrence risk is high (e.g., translocation carrier, advanced maternal age with recurrent aneuploidy).
β’ Genetic counselor and reproductive endocrinologist would coordinate this.
β Q11 (Examiner): βBeyond medical tests, what psychological and social support should you offer this mother?β
β Candidate's answer:
β’ Acknowledge her anxiety and validate her feelings (fear is normal).
β’ Ask about her support system (partner, family, friends).
β’ Connect her with parent support groups for families of children with Down syndrome (e.g., Down Syndrome Association, local parent groups).
β’ Discuss the possibility of speaking with another parent who has had a child with Down syndrome and then a healthy child.
β’ Ensure she does not feel pressured to make a decision β the choice about prenatal testing is hers alone.
β’ Offer referral to a perinatal mental health specialist if anxiety is severe.
β’ Reassure her that whatever decision she makes (to test or not, to continue or not continue a pregnancy) is the right decision for her family, and she will be supported.
β’ If her child with Down syndrome is not already in early intervention, refer to services.
β Q12 (Examiner): βShould the father also have karyotyping? Why or why not?β
β Candidate's answer:
β’ Yes, both parents should have karyotyping.
β’ A balanced translocation can be inherited from either parent. If the father carries a translocation (e.g., 45,XY,der(14;21)), the recurrence risk is lower (2-3%) but still significantly higher than the general population.
β’ If only the mother is tested and found to be normal, a paternal translocation could be missed, leading to an underestimation of recurrence risk.
β’ Testing both parents also helps clarify the origin of the translocation for other family members.
β’ If the father has a translocation, other paternal relatives (siblings) may also be at risk and could benefit from counseling.
β’ Exception: If the child with Down syndrome has standard trisomy 21 (not translocation) and both parents are young with no family history, the likelihood of a translocation in either parent is very low, but still recommended by many geneticists for completeness.
π£οΈ Examiner's probing / high-yield points (Down Syndrome Recurrence Counseling):
β’ "What is the most important first step before next pregnancy?" β Parental karyotyping (rule out translocation).
β’ "What is the recurrence risk for standard trisomy 21 after one affected child?" β ~1% plus maternal age risk.
β’ "What is the recurrence risk if mother is a balanced translocation carrier?" β 10-15%.
β’ "What is NIPT?" β Cell-free fetal DNA screening (NOT diagnostic).
β’ "What is the most accurate prenatal diagnostic test?" β Amniocentesis or CVS (karyotype).
β’ "Does folic acid prevent Down syndrome?" β No β it prevents neural tube defects.
β’ "Why refer to a genetic counselor?" β For precise risk calculation, test interpretation, and psychosocial support.
π Folic Acid Does NOT prevent Down syndrome. Prevents neural tube defects. Dose: 400-800 mcg daily.
β High-yield pearls for TOACS (Down Syndrome Recurrence Counseling):
β’ First step: Parental karyotyping (rule out translocation).
β’ Recurrence risk (standard trisomy): ~1% plus maternal age.
β’ If mother is translocation carrier: 10-15% risk.
β’ NIPT is screening (not diagnostic) β very high sensitivity but confirm with CVS/amnio.
β’ CVS (11-14 weeks) vs Amniocentesis (15-20 weeks) β both diagnostic.
β’ Folic acid does NOT prevent Down syndrome (prevents NTDs).
β’ Refer to genetic counselor β essential for complex cases.
β’ Psychosocial support is as important as medical counseling.